Profile data is unavailable for this security.
About the company
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is a China-based company principally engaged in the production, research, development and sale of chemical medicine and Chinese patent drugs. The Company's chemical medicine products mainly include Shapuaisi Bendazac Lysine Eye Drops, infusion products and cefixime products. The Company's Chinese patent drugs include kidney tonifying and nerve soothing products, such as Sizi Tianjing Capsules and Compound Gaoshan Hongjingtian Solution. The Company distributes its products in domestic market.
- Revenue in CNY (TTM)540.27m
- Net income in CNY-72.66m
- Incorporated2000
- Employees1.39k
- LocationZhejiang Shapuaisi Pharmaceutical Co LtdLumianjin BridgeChengbei Road, Pinghu CityJIAXING 314200ChinaCHN
- Phone+86 57 385021168
- Fax+86 57 385076188
- Websitehttp://www.zjspas.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ningbo Menovo Pharmaceutical Co Ltd | 1.24bn | -326.25k | 2.68bn | 2.35k | 8,619.72 | 1.27 | -- | 2.16 | -0.0323 | -0.0323 | 5.32 | 9.67 | 0.2802 | 1.29 | 5.28 | 527,886.10 | 0.0661 | 4.94 | 0.0989 | 7.83 | 29.16 | 35.39 | 0.2359 | 13.71 | 0.78 | 1.89 | 0.4176 | 10.78 | -16.51 | 7.46 | -96.58 | -34.53 | -6.03 | -32.54 |
Zhejiang Shapuaisi Pharmaceutical Co Ltd | 540.27m | -72.66m | 2.79bn | 1.39k | -- | 1.65 | -- | 5.16 | -0.1922 | -0.1922 | 1.44 | 4.46 | 0.2581 | 2.94 | 13.86 | 390,086.00 | -3.48 | -0.7573 | -4.00 | -0.8713 | 51.90 | 58.02 | -13.49 | -2.45 | 0.8094 | -- | 0.1284 | -- | 17.37 | 1.21 | -43.23 | -- | 30.36 | -- |
GuiZhou YiBai Pharmaceutical Co., Ltd. | 2.51bn | -131.00m | 2.81bn | 5.51k | -- | 1.03 | -- | 1.12 | -0.1654 | -0.1654 | 3.17 | 3.44 | 0.5335 | 1.48 | 10.54 | 455,445.80 | -3.01 | 0.8648 | -4.09 | 1.18 | 63.72 | 74.87 | -5.63 | 1.45 | 1.26 | -3.93 | 0.2515 | 216.36 | 3.12 | -6.19 | 124.25 | -- | -16.51 | -- |
Henan Taloph Pharmaceutical Stock Co Ltd | 2.00bn | 108.51m | 2.82bn | 2.35k | 26.44 | 1.80 | -- | 1.41 | 0.1857 | 0.1857 | 3.47 | 2.73 | 0.572 | 3.01 | 2.11 | 851,358.90 | 3.25 | 0.272 | 7.08 | 0.4981 | 28.52 | 27.97 | 5.68 | 0.5501 | 0.81 | 2.99 | 0.4312 | 28.70 | 5.57 | 11.62 | 160.32 | -- | -8.27 | -- |
Shanghai MicuRx Pharmaceutical Co Ltd | 109.40m | -497.31m | 2.89bn | 205.00 | -- | 4.41 | -- | 26.41 | -0.759 | -0.759 | 0.167 | 0.9991 | 0.0919 | 0.5886 | 5.18 | 533,680.30 | -41.76 | -- | -45.09 | -- | 81.44 | -- | -454.56 | -- | 7.87 | -- | 0.2914 | -- | 88.31 | -- | -91.16 | -- | -- | -- |
Data as of Oct 11 2024. Currency figures normalised to Zhejiang Shapuaisi Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 20.40k | 0.01% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 8.80k | 0.00% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 5.40k | 0.00% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 4.80k | 0.00% |
China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 2.60k | 0.00% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.